Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRecruitment status changed from Recruiting to Completed and enrollment updated to 235, with the page revision noted as v3.4.2 on 2026-02-13.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous v3.4.0. No substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedRelated topics such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed from the page, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedExpanded study overview and design details (Parts 1–4, RP2D determination and expansion, IR-NMIBC CR assessment) and updated status (Active, not recruiting), with a longer total duration (approximately 7 years 4 months).SummaryDifference2%

- Check39 days agoChange DetectedPage revision updated to v3.3.4 (removing v3.3.3); this is a minor site update that does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedNo significant content changes were detected on the Study Details page for NCT05316155. The page remains consistent with the previously displayed information, including title, study design, eligibility criteria, and outcome measures.SummaryDifference0.1%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.